These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 16825717)

  • 1. [Pyoderma gangrenosum, a nonintestinal manifestation of Lesniowski-Crohn's disease in a 15 years old girl].
    Müller L; Bala G; Kuczyńska R; Czerwionka-Szaflarska M
    Med Wieku Rozwoj; 2006; 10(2):463-73. PubMed ID: 16825717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous cyclosporine therapy in the treatment of pyoderma gangrenosum secondary to Crohn's disease.
    Carp JM; Onuma E; Das K; Gottlieb AB
    Cutis; 1997 Sep; 60(3):135-8. PubMed ID: 9314617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of infliximab in pyoderma gangrenosum.
    Hewitt D; Tait C
    Australas J Dermatol; 2007 May; 48(2):95-8. PubMed ID: 17535196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pyoderma gangrenosum: case report].
    Cavka V; Situm M; Poduje S; Brtan A; Mandusić N; Cubrilović Z
    Acta Med Croatica; 2012 Oct; 66 Suppl 1():25-8. PubMed ID: 23193817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A woman with painful ulcera on her lower leg].
    Schreuder RM; Horváth B; van Dullemen HM
    Ned Tijdschr Geneeskd; 2015; 159():A8783. PubMed ID: 26131750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of infliximab on extraintestinal manifestations of Crohn's disease.
    Kaufman I; Caspi D; Yeshurun D; Dotan I; Yaron M; Elkayam O
    Rheumatol Int; 2005 Aug; 25(6):406-10. PubMed ID: 15309501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favorable response to infliximab treatment in a patient with active Crohn disease and pyoderma gangrenosum.
    Triantafillidis JK; Cheracakis P; Sklavaina M; Apostolopoulou K
    Scand J Gastroenterol; 2002 Jul; 37(7):863-5. PubMed ID: 12190104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyoderma gangrenosum associated with inflammatory bowel disease. Report of two cases with good response to infliximab.
    Carrasco Cubero C; Ruiz Tudela MM; Salaberri Maestrojuan JJ; Pérez Venegas JJ
    Reumatol Clin; 2012; 8(2):90-2. PubMed ID: 22104047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythema nodosum progressing to pyoderma gangrenosum as a complication of Crohn's disease.
    Gellert A; Green ES; Beck ER; Ridley CM
    Postgrad Med J; 1983 Dec; 59(698):791-3. PubMed ID: 6657543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Healing of severe morbus Crohn-related pyoderma gangrenosum after colectomy].
    Henneberg J; Heidenheim M; Munck LK
    Ugeskr Laeger; 2021 Mar; 183(11):. PubMed ID: 33734075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
    Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
    Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab for treatment of resistant pyoderma gangrenosum associated with Crohn's disease.
    Ferkolj I; Hocevar A; Golouh R; Dolenc Voljc M
    Acta Dermatovenerol Alp Pannonica Adriat; 2006 Dec; 15(4):173-7. PubMed ID: 17982610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auricular pyoderma gangrenosum associated with Crohn's disease.
    Ben Chaabane N; Hellara O; Ben Mansour W; Ben Mansour I; Melki W; Loghmeri H; Safer L; Bdioui F; Saffar H
    Tunis Med; 2012 May; 90(5):414-5. PubMed ID: 22585655
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pyoderma gangrenosum in Crohn's disease].
    Baryshnikov EN; Neĭman KP
    Eksp Klin Gastroenterol; 2008; (5):92-4. PubMed ID: 19145923
    [No Abstract]   [Full Text] [Related]  

  • 15. Behçet's disease-like presentation of bullous pyoderma gangrenosum associated with Crohn's disease.
    Akay N; Boyvat A; Heper AO; Soykan I; Arica IE; Bektas M; Ensari A; Cokca F
    Clin Exp Dermatol; 2006 May; 31(3):384-6. PubMed ID: 16681583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease.
    Ampuero J; Rojas-Feria M; Castro-Fernández M; Cano C; Romero-Gómez M
    J Gastroenterol Hepatol; 2014 Feb; 29(2):291-5. PubMed ID: 23927379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extraintestinal manifestations of Crohn's disease.
    Juillerat P; Mottet C; Froehlich F; Felley C; Vader JP; Burnand B; Gonvers JJ; Michetti P
    Digestion; 2005; 71(1):31-6. PubMed ID: 15711047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractory pyoderma gangrenosum of the orbit and the lacrimal sac.
    Cordero-Coma M; Pérez-Moreiras JV; Toribio A; Alonso-Orcajo N; Calleja S; Franco M; Ruiz de Morales JG
    Orbit; 2012 Aug; 31(4):249-51. PubMed ID: 22571540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extraintestinal manifestations of Crohn's disease.
    Juillerat P; Mottet C; Pittet V; Froehlich F; Felley C; Gonvers JJ; Vader JP; Michetti P
    Digestion; 2007; 76(2):141-8. PubMed ID: 18239406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Peristomal pyoderma gangrenosum after colectomy for Crohn disease. Successful medical treatment].
    Goudet P; Pillon D; Bensa F; Collet E; Cougard P; Viard H
    Ann Chir; 1992; 46(6):525-9. PubMed ID: 1444154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.